Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse
Alle Filter löschen

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1022C3(10)
  2. 10C6(2)
  3. 10G10(2)
  4. 1121B(10)
  5. 11B11(4)
  6. 12B5(2)
  7. 148C09(10)
  8. 164#(10)
  9. 16D7(10)
  10. 16E7#(10)
  11. 17E6#(10)
  12. 17F3(4)
  13. 18#(2)
  14. 18A5(10)
  15. 1B4(10)
  16. 1D11.16.8(2)
  17. 1H4(10)
  18. 1H7(10)
  19. 2339#(10)
  20. 23F2G(10)
  21. 25D2(2)
  22. 2B8(10)
  23. 2c3(2)
  24. 2D9(2)
  25. 3(10)
  26. 30-H12(10)
  27. 30C10(10)
  28. 30H12(2)
  29. 31#(10)
  30. 320-587(10)
  31. 356A11(2)
  32. 368D04(2)
  33. 3B3(2)
  34. 3B6(10)
  35. 3C10(2)
  36. 3H9(10)
  37. 4A4(2)
  38. 5C8(10)
  39. 5E5#(10)
  40. 5F9-G4(10)
  41. 6(10)
  42. 60(10)
  43. 6A7(2)
  44. 6D6(2)
  45. 7(10)
  46. 70(2)
  47. 7A9(10)
  48. 7C6(4)
  49. 81C6(10)
  50. 8A4(2)
  51. 8D4-8(2)
  52. 8D5(10)
  53. 9H4(10)
  54. A12(10)
  55. A14(10)
  56. A2(10)
  57. A4(10)
  58. ab324(10)
  59. ABI793(2)
  60. Abituzumab(3)
  61. ABM109(2)
  62. Abrezekimab(2)
  63. Abrilumab(3)
  64. Adalimumab Beta(3)
  65. ADCT-301(10)
  66. ADCT-602(2)
  67. ADG 153(2)
  68. Afasevikumab(3)
  69. Afelimomab(2)
  70. Aflibercept(2)
  71. Alacizumab(2)
  72. ALX148(2)
  73. AMG 811(3)
  74. Anrukinzumab(3)
  75. AO-176(2)
  76. ARGX-112(3)
  77. Aselizumab(3)
  78. Asunercept(2)
  79. AT-1501(2)
  80. AT001(3)
  81. Atacicept(2)
  82. ATG 031(2)
  83. Atrosimab(3)
  84. Avizakimab(3)
  85. B122(2)
  86. B6H12(10)
  87. BAK209B11(2)
  88. Baminercept Alfa(2)
  89. Basiliximab(3)
  90. BAT6004(2)
  91. BD0801(2)
  92. Bectumomab(2)
  93. Belimumab(3)
  94. Benralizumab(3)
  95. Benufutamab(3)
  96. Bermekimab(3)
  97. Bersanlimab(3)
  98. Bevacizumab(3)
  99. Bexmarilimab(3)
  100. Bifikafusp Alfa(2)
  101. Bimekizumab(3)
  102. BION 1301(2)
  103. Bivatuzumab(3)
  104. BlySmAb-1.1(10)
  105. Brazikumab(3)
  106. Briakinumab(3)
  107. Briobacept(2)
  108. Brolucizumab(2)
  109. BT-063(3)
  110. Burfiralimab(2)
  111. C17.8(2)
  112. C2_2E12(2)
  113. Camidanlumab(3)
  114. Camoteskimab(3)
  115. Canakinumab(3)
  116. Cantuzumab(2)
  117. CAT-02-106(2)
  118. CAT-2200(3)
  119. CC-90002(3)
  120. CDP484(3)
  121. CDP571(2)
  122. CDX-0125-TEI(2)
  123. Cendakimab(3)
  124. Certolizumab(2)
  125. Clazakizumab(3)
  126. Clivatuzumab(3)
  127. CMAB008(3)
  128. CMB-401(2)
  129. CNTO 607(3)
  130. Conatumumab(3)
  131. Conbercept(2)
  132. CYT-91000(2)
  133. D1(10)
  134. D2(4)
  135. D8P1C1(2)
  136. Daclizumab(3)
  137. Dapirolizumab(2)
  138. DC101(12)
  139. Dectrekumab(3)
  140. Denosumab(3)
  141. Depemokimab(3)
  142. Dilpacimab(2)
  143. DISC0280(3)
  144. DLX521(2)
  145. Dovanvetmab(2)
  146. Dreg-55(10)
  147. Drozitumab(3)
  148. DS-8273a(3)
  149. Dupilumab(3)
  150. Dusigitumab(3)
  151. Duvakitug(3)
  152. E4#(20)
  153. Ebdarokimab(3)
  154. Efalizumab(3)
  155. Efdamrofusp Alfa(2)
  156. Eflimrufusp Alfa(2)
  157. Eftozanermin Alfa(2)
  158. Elsilimomab(2)
  159. Emapalumab(3)
  160. ENA2(10)
  161. Enavatuzumab(3)
  162. Enlimomab(3)
  163. Enokizumab(3)
  164. Epitumomab cituxetan(2)
  165. Epratuzumab(5)
  166. Eptinezumab(3)
  167. Erlizumab(3)
  168. ESBA 105(3)
  169. Etanercept(2)
  170. Etokimab(3)
  171. Etrolizumab(3)
  172. F16(10)
  173. Faricimab(2)
  174. FD441.8(10)
  175. Fezakinumab(3)
  176. Fletikumab(3)
  177. Fontolizumab(3)
  178. Fremanezumab(3)
  179. Fresolimumab(3)
  180. Frexalimab(3)
  181. G28-8(10)
  182. G544(10)
  183. G6(2)
  184. GAL-F2(2)
  185. Galcanezumab(3)
  186. Gatipotuzumab(3)
  187. Gevokizumab(3)
  188. Golimumab(3)
  189. GSK679586(3)
  190. Gumokimab(3)
  191. Guselkumab(3)
  192. H2L6(3)
  193. H398(10)
  194. H4H10(2)
  195. H5(10)
  196. H52(2)
  197. H6(20)
  198. HB 9579(10)
  199. HFE7A(10)
  200. HM1.24(10)
  201. hMAK195(3)
  202. HMBD-004A(2)
  203. HMBD-004B(2)
  204. HMFG1(10)
  205. HMPL-a83(2)
  206. hRFB4(2)
  207. HuGAL-F2(3)
  208. hum12G8(2)
  209. HuMax-IL15(3)
  210. huS6F1(2)
  211. HW1(10)
  212. IMA-026(3)
  213. IMC-002(2)
  214. IMC-1C11(2)
  215. ImClone 6.64(3)
  216. IMM01(2)
  217. Immurait-Ll2Mab(3)
  218. Inbakicept(2)
  219. Infliximab(3)
  220. Inolimomab(3)
  221. Inotuzumab(3)
  222. Itepekimab(3)
  223. Iv0058(4)
  224. Ivonescimab(2)
  225. Ixekizumab(3)
  226. JCAR018(2)
  227. JES6-1A12(4)
  228. KHK2866(3)
  229. L117/1(2)
  230. L120/12(2)
  231. L120/30(2)
  232. L19-TNF(3)
  233. Latikafusp(2)
  234. LDP-01(2)
  235. Lebrikizumab(3)
  236. Lemzoparlimab(3)
  237. Lenercept(2)
  238. Letaplimab(3)
  239. Letolizumab(2)
  240. Lexatumumab(3)
  241. Licaminlimab(2)
  242. Ligufalimab(3)
  243. Livmoniplimab(2)
  244. LL2(10)
  245. Lutikizumab(2)
  246. LY2525623(3)
  247. LY3016859(2)
  248. M1295(3)
  249. M17/4(12)
  250. M3A1(2)
  251. M3B8(2)
  252. M971(3)
  253. M972(3)
  254. Mab1(10)
  255. Magrolimab(3)
  256. Manfidokimab(3)
  257. Mapatumumab(3)
  258. MEDI 5117(3)
  259. MEDI2045(3)
  260. MEDI3185(2)
  261. MEDI3622(2)
  262. Mepolizumab(3)
  263. Metelimumab(3)
  264. MIAP410(2)
  265. Mirikizumab(3)
  266. MO82(2)
  267. MOR101(2)
  268. MOR102(2)
  269. Moxetumomab(2)
  270. MP5-20F3(2)
  271. MR-1(2)
  272. MR1/MR-1(10)
  273. N178A/9(2)
  274. N212/17(2)
  275. N212/7(2)
  276. N275/14(2)
  277. N295B/66(2)
  278. N324/2(2)
  279. N384/63(2)
  280. N39B/8(2)
  281. N4/15(2)
  282. N4/49(2)
  283. N83/48(2)
  284. Nacolomab(2)
  285. Natalizumab(3)
  286. Navicixizumab(2)
  287. Neihulizumab(3)
  288. Nerelimomab(3)
  289. Netakimab(3)
  290. NI-1701(2)
  291. NIS793(3)
  292. NOK1/NOK-1(10)
  293. NOK2/NOK-2(10)
  294. Odulimomab(3)
  295. Olamkicept(2)
  296. Olinvacimab(3)
  297. Olokizumab(3)
  298. Ontamalimab(3)
  299. Ontorpacept(2)
  300. Opinercept(2)
  301. OV52.24(10)
  302. Ozoralizumab(2)
  303. P4D2(10)
  304. Pankomab(3)
  305. Parsatuzumab(3)
  306. Pascolizumab(3)
  307. Pateclizumab(3)
  308. PC-61.5.3(2)
  309. PC61/PC61.5.3(10)
  310. Pemtumomab(2)
  311. Perakizumab(3)
  312. PF-03475952(2)
  313. Pinatuzumab(3)
  314. Placulumab(2)
  315. Pritumumab(3)
  316. PS/2(2)
  317. PTX25(10)
  318. Pulocimab(2)
  319. R310(2)
  320. R4-6A2(2)
  321. R6N(10)
  322. RA8(2)
  323. Rademikibart(3)
  324. Radretumab(2)
  325. Ramucirumab(3)
  326. Ranibizumab(2)
  327. REGN1909(2)
  328. Remtolumab(2)
  329. Reslizumab(3)
  330. RFB-4(10)
  331. RG7356(2)
  332. Rilonacept(2)
  333. Risankizumab(3)
  334. RO5458640(3)
  335. RO7296682(2)
  336. Romilkimab(2)
  337. Rovelizumab(2)
  338. Rozipafusp alfa(2)
  339. RTX-003(2)
  340. RTX-CD47(2)
  341. Ruplizumab(3)
  342. S4B6(2)
  343. S4B6-1(2)
  344. SAA0004(20)
  345. SAA0008(10)
  346. SAA0019(10)
  347. SAA0020(10)
  348. SAA0025(10)
  349. SAA0026(10)
  350. SAA0040(10)
  351. SAA0046(10)
  352. SAA0047(10)
  353. SAA0065(10)
  354. SAA0067(10)
  355. SAA0068(10)
  356. SAA0075(10)
  357. SAA0079(10)
  358. SAA0080(10)
  359. SAA0081(10)
  360. SAA0083(10)
  361. SAA0084(10)
  362. SAA0085(10)
  363. SAA0112(10)
  364. SAA0147(10)
  365. SAA0173(10)
  366. SAA0196(2)
  367. SAA0239(2)
  368. SAA0266(2)
  369. SAA0281(2)
  370. SAA0309(2)
  371. SAA0312(10)
  372. SAA0366(10)
  373. SAA0367(10)
  374. SAA0368(10)
  375. SAA0369(10)
  376. SAA0370(10)
  377. SAA0371(10)
  378. SAA0372(10)
  379. SAA0373(10)
  380. SAA0374(10)
  381. SAA0375(10)
  382. SAA0377(10)
  383. SAA0378(10)
  384. SAA0381(10)
  385. SAA0382(10)
  386. SAA0383(10)
  387. SAA0384(10)
  388. SAA0386(10)
  389. SAA0387(10)
  390. SAA0389(10)
  391. SAA0390(10)
  392. SAA0391(10)
  393. SAA0392(10)
  394. SAA0393(10)
  395. SAA0394(10)
  396. SAA0395(10)
  397. SAA0414(10)
  398. SAA0415(10)
  399. SAA0416(10)
  400. SAA0421(10)
  401. SAA0423(10)
  402. SAA0432(10)
  403. SAA0436(10)
  404. SAA0437(10)
  405. SAA0440(10)
  406. SAA0442(10)
  407. SAA0443(10)
  408. SAA0446(10)
  409. SAA0447(10)
  410. SAA0453(10)
  411. SAA0483(10)
  412. SAA0511(10)
  413. SAA0513(10)
  414. SAA0549(10)
  415. SAA0763(10)
  416. SAA0768(2)
  417. SAA0806(10)
  418. SAA0815(10)
  419. SAA1383(10)
  420. SAA1403(10)
  421. SAA1413(10)
  422. SAA1487(10)
  423. SAA1992(10)
  424. SAA2157(10)
  425. SAA2180(10)
  426. SAA2212(10)
  427. SAA2216(10)
  428. SAA2219(10)
  429. SAR-566658(2)
  430. SAR113244(3)
  431. SAR428926(3)
  432. sB24M(2)
  433. Secukinumab(3)
  434. SG404(2)
  435. SGN CD47M(2)
  436. Sibeprenlimab(3)
  437. Siltuximab(3)
  438. Simridarlimab(2)
  439. Sirukumab(3)
  440. SM06(2)
  441. SM3(2)
  442. Sontuzumab(3)
  443. SRF231(2)
  444. SRK-181(3)
  445. SSS-23(10)
  446. ST2146(10)
  447. Stapokibart(3)
  448. STI-003(2)
  449. STI-6643(2)
  450. Suciraslimab(2)
  451. SWA11(10)
  452. T24/31(10)
  453. TAB004(2)
  454. Tabalumab(3)
  455. Tanibirumab(2)
  456. Tarcocimab(2)
  457. TAS266(4)
  458. TAY018(2)
  459. Temtokibart(3)
  460. Tenatumomab(2)
  461. TI-061(2)
  462. Tibulizumab(2)
  463. Tigatuzumab(3)
  464. Tildrakizumab(3)
  465. Tilogotamab(3)
  466. TJ-C4GM(2)
  467. Toralizumab(2)
  468. Torudokimab(3)
  469. Tozorakimab(3)
  470. TQB 2928(2)
  471. Tralokinumab(3)
  472. TTI-621(2)
  473. TTI-622(2)
  474. Tulisokibart(3)
  475. Ulocuplumab(3)
  476. Urabrelimab(3)
  477. Ustekinumab(3)
  478. VAK-694(2)
  479. Vanucizumab(2)
  480. Varisacumab(3)
  481. VB6(10)
  482. VB6-008(2)
  483. Vedolizumab(3)
  484. VFF-18(10)
  485. VGX100(3)
  486. VIS-649(10)
  487. Vopikitug(3)
  488. Vulinacimab(3)
  489. Vunakizumab(3)
  490. Vx-1004(2)
  491. Xeligekimab(2)
  492. Xentuzumab(3)
  493. XmAb 5592(3)
  494. XMG1.2(4)
  495. XOMA 089(2)
  496. XT3.11(2)
  497. YT33(2)
  498. Ziltivekimab(3)
  499. ZL-1201(2)
Applications
Isotype

Cell Biology

5419 Artikel

pro Seite

Seite:
  1. 136
  2. 137
  3. 138
  4. 139
  5. 140
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Research Grade Abrilumab Biosimilars Abrilumab Hu Human ANSY-DHC98804-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Abituzumab Biosimilars Abituzumab Hu ANSY-DHC21901-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Bersanlimab Biosimilars Bersanlimab Hu Human ANSY-DHC16001-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Enlimomab Biosimilars Enlimomab Hu Mouse ANSY-DHC16002-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Aselizumab Biosimilars Aselizumab Hu ANSY-DHD03301-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Letolizumab Letolizumab Hu ANSY-DHD85401-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Dapirolizumab Dapirolizumab Hu ANSY-DHD85402-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Ruplizumab Biosimilars Ruplizumab Hu ANSY-DHD85403-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Toralizumab Toralizumab Hu ANSY-DHD85404-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Tenatumomab Tenatumomab Hu Mouse ANSY-DHD64001-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Ulocuplumab Biosimilars Ulocuplumab Hu Human ANSY-DHF39901-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Gatipotuzumab Biosimilars Gatipotuzumab Hu ANSY-DHD14201-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Sontuzumab Biosimilars Sontuzumab Hu ANSY-DHD14202-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Cantuzumab Cantuzumab Hu ANSY-DHD14203-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Nacolomab Nacolomab Hu Mouse ANSY-DHD14204-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Clivatuzumab Biosimilars Clivatuzumab Hu ANSY-DHD14205-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Epitumomab Epitumomab cituxetan Hu Mouse ANSY-DHD14206-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Pankomab Biosimilars Pankomab Hu Human ANSY-DHD14207-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Mapatumumab Biosimilars Mapatumumab Hu Human ANSY-DHA05901-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Benufutamab Biosimilars Benufutamab Hu ANSY-DHA29101-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Tigatuzumab Biosimilars Tigatuzumab Hu ANSY-DHA29102-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Conatumumab Biosimilars Conatumumab Hu Human ANSY-DHA29103-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Drozitumab Biosimilars Drozitumab Hu Human ANSY-DHA29104-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Lexatumumab Biosimilars Lexatumumab Hu Human ANSY-DHA29105-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Tilogotamab Biosimilars Tilogotamab Hu ANSY-DHA29106-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Name Preis
Research Grade Abrilumab Anmelden Research Grade Abrilumab
Typ Biosimilars
Clone Abrilumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Abituzumab Anmelden Research Grade Abituzumab
Typ Biosimilars
Clone Abituzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Bersanlimab Anmelden Research Grade Bersanlimab
Typ Biosimilars
Clone Bersanlimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Enlimomab Anmelden Research Grade Enlimomab
Typ Biosimilars
Clone Enlimomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Aselizumab Anmelden Research Grade Aselizumab
Typ Biosimilars
Clone Aselizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Letolizumab Anmelden Research Grade Letolizumab
Typ
Clone Letolizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Dapirolizumab Anmelden Research Grade Dapirolizumab
Typ
Clone Dapirolizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Ruplizumab Anmelden Research Grade Ruplizumab
Typ Biosimilars
Clone Ruplizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Toralizumab Anmelden Research Grade Toralizumab
Typ
Clone Toralizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Tenatumomab Anmelden Research Grade Tenatumomab
Typ
Clone Tenatumomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Ulocuplumab Anmelden Research Grade Ulocuplumab
Typ Biosimilars
Clone Ulocuplumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Gatipotuzumab Anmelden Research Grade Gatipotuzumab
Typ Biosimilars
Clone Gatipotuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Sontuzumab Anmelden Research Grade Sontuzumab
Typ Biosimilars
Clone Sontuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Cantuzumab Anmelden Research Grade Cantuzumab
Typ
Clone Cantuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Nacolomab Anmelden Research Grade Nacolomab
Typ
Clone Nacolomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Clivatuzumab Anmelden Research Grade Clivatuzumab
Typ Biosimilars
Clone Clivatuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Epitumomab Anmelden Research Grade Epitumomab
Typ
Clone Epitumomab cituxetan
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Pankomab Anmelden Research Grade Pankomab
Typ Biosimilars
Clone Pankomab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Mapatumumab Anmelden Research Grade Mapatumumab
Typ Biosimilars
Clone Mapatumumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Benufutamab Anmelden Research Grade Benufutamab
Typ Biosimilars
Clone Benufutamab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Tigatuzumab Anmelden Research Grade Tigatuzumab
Typ Biosimilars
Clone Tigatuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Conatumumab Anmelden Research Grade Conatumumab
Typ Biosimilars
Clone Conatumumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Drozitumab Anmelden Research Grade Drozitumab
Typ Biosimilars
Clone Drozitumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Lexatumumab Anmelden Research Grade Lexatumumab
Typ Biosimilars
Clone Lexatumumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Tilogotamab Anmelden Research Grade Tilogotamab
Typ Biosimilars
Clone Tilogotamab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar

5419 Artikel

pro Seite

Seite:
  1. 136
  2. 137
  3. 138
  4. 139
  5. 140
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top